BRPI0511209A - composição farmacêutica e uso de uma associação de propionato de clobetasol e de calcitriol - Google Patents
composição farmacêutica e uso de uma associação de propionato de clobetasol e de calcitriolInfo
- Publication number
- BRPI0511209A BRPI0511209A BRPI0511209-5A BRPI0511209A BRPI0511209A BR PI0511209 A BRPI0511209 A BR PI0511209A BR PI0511209 A BRPI0511209 A BR PI0511209A BR PI0511209 A BRPI0511209 A BR PI0511209A
- Authority
- BR
- Brazil
- Prior art keywords
- calcitriol
- pharmaceutical composition
- combination
- clobetasol propionate
- clobetasol
- Prior art date
Links
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 title abstract 3
- 229960005084 calcitriol Drugs 0.000 title abstract 3
- 235000020964 calcitriol Nutrition 0.000 title abstract 3
- 239000011612 calcitriol Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229960004703 clobetasol propionate Drugs 0.000 title abstract 2
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 title abstract 2
- 201000004681 Psoriasis Diseases 0.000 abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 abstract 1
- 229960002842 clobetasol Drugs 0.000 abstract 1
- FCSHDIVRCWTZOX-DVTGEIKXSA-N clobetasol Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O FCSHDIVRCWTZOX-DVTGEIKXSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
COMPOSIçãO FARMACêUTICA E USO DE UMA ASSOCIAçãO DE PROPIONATO DE CLOBETASOL E DE CALCITRIOL A presente invenção tem por objeto uma composição farmacêutica destinada ao tratamento da psoríase, caracterizada pelo fato de compreender propionato de clobetasol e calcitriol em uma quantidade apropriada para uma aplicação uma vez por dia sobre a ou as partes da pele afetada(s) pela psoríase.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0406608A FR2871693B1 (fr) | 2004-06-17 | 2004-06-17 | Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis |
PCT/FR2005/001348 WO2006008354A1 (fr) | 2004-06-17 | 2005-06-01 | Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0511209A true BRPI0511209A (pt) | 2007-11-27 |
Family
ID=34946514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0511209-5A BRPI0511209A (pt) | 2004-06-17 | 2005-06-01 | composição farmacêutica e uso de uma associação de propionato de clobetasol e de calcitriol |
Country Status (16)
Country | Link |
---|---|
US (1) | US20050282792A1 (pt) |
EP (1) | EP1758587B1 (pt) |
JP (1) | JP2008502659A (pt) |
CN (1) | CN1968702A (pt) |
AR (1) | AR049517A1 (pt) |
AT (1) | ATE480242T1 (pt) |
AU (1) | AU2005263804A1 (pt) |
BR (1) | BRPI0511209A (pt) |
CA (1) | CA2568753A1 (pt) |
DE (1) | DE602005023452D1 (pt) |
ES (1) | ES2351045T3 (pt) |
FR (1) | FR2871693B1 (pt) |
MX (1) | MXPA06014410A (pt) |
RU (1) | RU2007101538A (pt) |
WO (1) | WO2006008354A1 (pt) |
ZA (1) | ZA200700233B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2912655A1 (fr) * | 2007-02-15 | 2008-08-22 | Galderma Sa | Produit de soin cutane a double compartiment comprenant du calcitriol et du propionate de clobetasol, et son utilisation |
US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
EP1970048A1 (en) * | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with vitamin D |
EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
ES2489615T3 (es) | 2007-12-11 | 2014-09-02 | Apoteknos Para La Piel, S.L. | Uso de un compuesto derivado del acido p-hidroxifenil propionico para el tratamiento de la psoriasis |
HUE045467T2 (hu) | 2011-03-14 | 2020-01-28 | Drug Delivery Solutions Ltd | Szemészeti készítmény |
JP6371312B2 (ja) | 2013-01-29 | 2018-08-08 | アヴェクシン エーエス | 坑炎症および抗腫瘍2−オキソチアゾール化合物ならびに2−オキソチオフェン化合物 |
CN103142466B (zh) * | 2013-03-21 | 2015-04-22 | 青岛正大海尔制药有限公司 | 骨化三醇凝胶及其制备方法 |
GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
JP2019529555A (ja) | 2016-09-21 | 2019-10-17 | アヴェクシン エーエス | 医薬組成物 |
JPWO2018230713A1 (ja) * | 2017-06-16 | 2020-04-16 | 学校法人同志社 | カスパーゼ阻害活性を有する化合物、これらの化合物を含む、角膜内皮の症状、障害または疾患を治療または予防するための医薬およびその応用 |
US11433090B2 (en) | 2017-06-16 | 2022-09-06 | The Doshisha | mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6126949A (en) * | 1998-04-06 | 2000-10-03 | Bernel Chemical Company, Inc. | Di-behenyl fumarate and its use in dermatological products |
PT1178808E (pt) * | 1999-04-23 | 2012-08-16 | Leo Pharma As | Composição farmacêutica não aquosa para utilização dérmica para o tratamento da psoríase compreendendo uma vitamina d, um corticosteróide e de um componente solvente |
EP1331927B1 (en) * | 2000-10-27 | 2007-12-12 | Leo Pharma A/S | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
FR2848454B1 (fr) * | 2002-12-17 | 2007-03-30 | Galderma Res & Dev | Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide |
CA2505406A1 (en) * | 2002-12-17 | 2004-07-01 | Galderma Sa | Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate |
-
2004
- 2004-06-17 FR FR0406608A patent/FR2871693B1/fr not_active Expired - Fee Related
- 2004-09-17 US US10/942,997 patent/US20050282792A1/en not_active Abandoned
-
2005
- 2005-06-01 MX MXPA06014410A patent/MXPA06014410A/es not_active Application Discontinuation
- 2005-06-01 WO PCT/FR2005/001348 patent/WO2006008354A1/fr active Application Filing
- 2005-06-01 EP EP05775762A patent/EP1758587B1/fr active Active
- 2005-06-01 BR BRPI0511209-5A patent/BRPI0511209A/pt not_active IP Right Cessation
- 2005-06-01 AU AU2005263804A patent/AU2005263804A1/en not_active Abandoned
- 2005-06-01 ES ES05775762T patent/ES2351045T3/es active Active
- 2005-06-01 DE DE602005023452T patent/DE602005023452D1/de active Active
- 2005-06-01 RU RU2007101538/15A patent/RU2007101538A/ru unknown
- 2005-06-01 JP JP2007515980A patent/JP2008502659A/ja not_active Ceased
- 2005-06-01 CN CNA2005800200384A patent/CN1968702A/zh active Pending
- 2005-06-01 AT AT05775762T patent/ATE480242T1/de not_active IP Right Cessation
- 2005-06-01 CA CA002568753A patent/CA2568753A1/fr not_active Abandoned
- 2005-06-16 AR ARP050102465A patent/AR049517A1/es unknown
-
2007
- 2007-01-09 ZA ZA200700233A patent/ZA200700233B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200700233B (en) | 2007-12-27 |
RU2007101538A (ru) | 2008-07-27 |
AR049517A1 (es) | 2006-08-09 |
CA2568753A1 (fr) | 2006-01-26 |
FR2871693B1 (fr) | 2006-08-25 |
ES2351045T3 (es) | 2011-01-31 |
DE602005023452D1 (de) | 2010-10-21 |
WO2006008354A1 (fr) | 2006-01-26 |
ATE480242T1 (de) | 2010-09-15 |
AU2005263804A1 (en) | 2006-01-26 |
FR2871693A1 (fr) | 2005-12-23 |
US20050282792A1 (en) | 2005-12-22 |
EP1758587B1 (fr) | 2010-09-08 |
JP2008502659A (ja) | 2008-01-31 |
MXPA06014410A (es) | 2007-02-19 |
EP1758587A1 (fr) | 2007-03-07 |
CN1968702A (zh) | 2007-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0511209A (pt) | composição farmacêutica e uso de uma associação de propionato de clobetasol e de calcitriol | |
BRPI0410503A (pt) | uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição | |
BRPI0114927B8 (pt) | composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição | |
CR9949A (es) | Inhibidores de proteina activadora de la 5-lipoxigenasa (flap) | |
BR112015015908A2 (pt) | equipamento para ostomia de uma peça ou de duas peças, placa de base para um equipamento para ostomia, elemento convexo para uso em uma placa de base, e, uso de um material | |
ATE543813T1 (de) | Neue benzopyranderivate als kaliumkanalöffner | |
BR112014014181A2 (pt) | combinação de ozogamicina inotuzumab e torisel para o tratamento de câncer | |
CR8428A (es) | Agente endoparasiticidas para la administracion topica | |
BRPI0617294B8 (pt) | composição farmacêutica em gel hidroalcóolico e uso de testosterona | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
CL2009001484A1 (es) | Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia. | |
BRPI0923589A2 (pt) | uso de uma composição espumável essencialmente livre de ingredientes farmaceuticamente ativos para o tratamento da pele humana. | |
BRPI0513145A (pt) | conjugados de amino, aminoácido ou peptìdeo de ácido retinóico | |
ATE410424T1 (de) | Spirocyclische cyclohexan-derivate | |
BRPI0510938A (pt) | vitamina k1 como energizador em formulações cosméticas | |
CR10305A (es) | "derivados sustituidos de cromanol y su uso. | |
BRPI0518855A2 (pt) | medicamento para aplicaÇço higiÊnica no ouvido | |
BRPI0809079A2 (pt) | tratamento de câncer com um combinado de il-18 humana e anticorpo anti-cd20 | |
BRPI0511398A (pt) | composição farmacêutica anidra para o tratamento da psorìase e uso de um agente siliconado | |
TR201004464A2 (tr) | Kemik erimesi için formülasyon. | |
UA104994C2 (uk) | Придатна для розпилення композиція, що містить екстракт із листя червоного винограду | |
BR112012027393A2 (pt) | composto da fórmula geral i, composição farmacêutica, uso de um composto e método de tratamento de qualquer mamífero, notadamente um humano, afetado por câncer | |
BRPI0507157A (pt) | uso de fator viia ou de um equivalente de fator viia, kit de partes para tratamento de trauma, e, métodos para tratar trauma e para prevenir, tratar trauma | |
PT1220676E (pt) | Prevencao do cancro colorrectal | |
BRPI0807207A2 (pt) | Composto que inibe metalo-ectopeptidase, composição contendo composto, uso do composto e processo de tratamento cosmético da pele humana ou na membrana mucosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DA 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013. |